tm logo

Monitor this mark

View On USPTO

LYTENAVA
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 22 May 2024

Last Applicant/ Owned by

Outlook Therapeutics, Inc.

485 Route 1 South, Building F, Suite 320

Iselin

NJ

08830

Serial Number

88872045 filed on 14th Apr 2020

Registration Number

N/A

Correspondent Address

Ariana G. Hiscott

Ariana G. Hiscott COOLEY LLP

WASHINGTON, DC 20004-2400

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

LYTENAVA

injectable pharmaceutical preparations for the treatment of retinal disease; pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease

Classification Information

Class [005]
Pharmaceutical Products

injectable pharmaceutical preparations for the treatment of retinal disease; pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease

First Use Date in General

29th Aug 2022

First Use Date in Commerce

29th Aug 2022

Mark Details

Serial Number

No 88872045

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 325849-20000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
22nd May 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
22nd May 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
05th Feb 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
05th Feb 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
08th Nov 2023NON-FINAL ACTION E-MAILED
08th Nov 2023SU - NON-FINAL ACTION - WRITTEN
08th Nov 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
18th Sep 2023STATEMENT OF USE PROCESSING COMPLETE
14th Sep 2023USE AMENDMENT FILED
14th Sep 2023TEAS STATEMENT OF USE RECEIVED